Interval cytoreduction with HIPEC (Hyperthermic Intraperitoneal chemotherapy) signficantly improves Recurrence free survival and overall survival when compared to surgery without HIPEC in stage 3 epithelial ovarian cancer
You can find the abstract here
Results of DESKTOP III ( Progression Free Survival) have been published recently in ASCO Abstracts
The median Progression free survival in patients undergoing secondary cytoreduction for relapsed ovarian cancer (with 6 months plus platinum free interval, positive AGO score ie., ECOG 0,<500 mL Ascites, complete resection at first surgery) was 19.6 months versus 14 months without surgery.
The abstract can be accessed here
यो न ह्रुष्यति न द्वेष्टि न शोचाति न काङ्क्षति |
शुभाशुभपरित्यागी भक्तिमान्यः स मे प्रियः ||
Chapter 12 Verse 17
He who neither rejoices nor hates nor grieves nor sesires, renouncing good and evil,full of devotion, he is dear to me.
कर्मण्यकर्म यः पश्येदकर्मणि च यः|
स बुद्धिमान्मनुष्येषु स युक्तः कृत्स्नकर्मक्र्त ||
He who sees inaction in action, and action in inaction, he is wise among men, he is a yogi and accomplisher of everything
Chapter 4 verse 18
कायेन मनसा बुद्ध्या केवलैरिन्द्रियैरपि |
योगिनः कर्म कुर्वन्ति सङ्गं त्यक्त्वात्मशुद्धये ||
Chapter 5 Verse 11
The Yogi, abandoning attachment, performs work with the body, the mind, the intellect and the senses only, for self-purification.
Findings from a prospective study has suggested that prophylactic oophorectomy may play a role in prevention of premenopausal breast cancer in BRCA 2 mutation carriers but not in BRCA 1 .
You can find the link to the study here